Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltegravir pharmacokinetics and tolerability in the third trimester of pregnancy
2013-004571-12Phase 2Completed
- Sponsor
- Inserm-ANRS
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of raltegravir in Human immunodeficiency virus infection type 1, sponsored by Inserm-ANRS. Primary endpoint: Raltegravir AUC and trough concentration during pregnancy versus postpartum. Started Jun 2015; status: completed.
02
Drugs
raltegravir
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2013-004571-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004571-12.